Shopping Cart
- Remove All
Your shopping cart is currently empty
Antitumor agent-133 (compound 4d) is a bis-santine derivative that demonstrates activity against Huh1 (IC50 = 17.13 μM) and Huh7 (IC50 = 8.27 μM). It induces autophagy and inhibits tumor growth by modulating the levels of the LC3BII, ATG5, and p62 proteins.

| Description | Antitumor agent-133 (compound 4d) is a bis-santine derivative that demonstrates activity against Huh1 (IC50 = 17.13 μM) and Huh7 (IC50 = 8.27 μM). It induces autophagy and inhibits tumor growth by modulating the levels of the LC3BII, ATG5, and p62 proteins. |
| In vitro | Antitumor agent-133 selectively targets cancer cells. At concentrations ranging from 0 to 100 μM over 48 hours, it induces autophagy by modulating the expression of LC3B (I and II), ATG5, and p62. |
| In vivo | Antitumor agent-133 (15 mg/kg, intraperitoneal injection, administered every other day for a total of 14 days) effectively inhibits tumor growth in the Huh1 xenograft model in NCG mice and exhibits low toxicity. |
| Formula | C27H24Br2N4O8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.